our Human Resources policy

The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.

Filter by category
  • All
  • Blog
  • Congress
  • Scientific resource
  • Webinar
  • Poster
  • Scientific publication
  • Press release
  • Press coverage
  • News
Filter by category
loader
Scientific paper - Ressources
Poster
28/03/2023

OncoTAM, a comprehensive preclinical platform to explore macrophages

OncoTAM targets Tumor Associated Macrophages to develop new Anticancer Therapies in a form of a comprehensive preclinical platform. Learn more here

Scientific paper - Ressources
Poster
28/03/2023

Simultaneous 18F-FDG PET / MR imaging for metastases identification in a disseminated human preclinical melanoma model

Simultaneous 18F-FDG PET / MR imaging for metastases identification in a disseminated human preclinical Melanoma Model. Learn more here

Scientific paper - Ressources
Poster
28/03/2023

Antitumor activity comparison of two somatostatin receptor ligands radiolabeled with Lutetium-177 (SSO110 and DOTA-TATE)

Somatostatin Receptor ligands Antitumor Activity comparison radiolabeled with Lutetium 177 alone or combined with chemotherapy in mice. Learn more here

Congress
14/03/2023

AACR Annual Meeting 2023

The AACR Annual Meeting brings together scientists, clinicians, and other professionals to share the latest advances in cancer science. Learn more here

Scientific publication
06/03/2023

Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases

New study investigates Pharmacological Inhibitors of DYRK and CLK Protein Kinases and their comparative efficacy and selectivity. Learn more here

Scientific resource
21/02/2023

IBD Case study

Discover an example of a screening cascade developed by Oncodesign Services that led to the identification of preclinical candidates.

Congress
21/02/2023

Oncodesign Services Events in March 2023

Oncodesign is taking part in many events this March. Here is a short selection of where we are travelling over the next few weeks. Learn more here

10/02/2023

The International Day of Women and Girls in Science

We met with women employees of Oncodesign Services to talk their careers and their ambitions for a better valorization of women in Science. Learn more here

Blog
02/02/2023

Why preclinical cancer models still fails in the clinic?

We at Oncodesign Services strive to develop alternative Preclinical Cancer Models to better suit your drug development. Read more about our solutions here.

Scientific publication
16/01/2023

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer

Liposomal Irinotecan is hypothesized to have a higher therapeutic index than its non-liposomal counterpart in mice with Pancreatic Cancer. Read more here.